Abiopharma

🔍 FOSTER STEVEN M (Director)

Company: Tenon Medical, Inc. (TNON)

Report Date: 2026-01-01

Detailed Transactions and Holdings:

• Acquired 140,936 shares of Common Stock (Direct)
  Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 163,814.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 140,936 shares of Restricted Stock Units (Derivative)
  Date: 2026-01-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 140,936.00 | transaction_form_type: 4 | Footnotes: F1, F2, F1, F1

Footnotes:

• F1: Represents conversion of 140,936 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 140,936 shares of common stock of the Issuer on January 1, 2026.
• F2: Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.